Patents Assigned to Spinogenix, Inc.
  • Solid forms of a promoter of spinogenesis
    Patent number: 12486287
    Abstract: Provided herein are crystalline forms of 2-(2-(2-(2-(4-(benzo[d]thiazol-2-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethan-1-ol (Compound I): Also provided are processes of manufacture and methods of using the crystalline forms.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: December 2, 2025
    Assignee: Spinogenix, Inc.
    Inventors: Stella T. Sarraf, Elizabeth Büchler Vadas
  • Benzothiazole and related compounds
    Patent number: 12391659
    Abstract: Disclosed are compounds that promote spinogenesis, are capable of reducing the neural toxicity of beta-amyloid peptides, and/or reduce the symptoms of traumatic brain injury in a patient.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: August 19, 2025
    Assignee: Spinogenix, Inc.
    Inventors: Stella Sarraf, Vincent F. Simmon, Gerald F. Swiss
  • Benzothiazole and related compounds
    Patent number: 11117878
    Abstract: Disclosed are compounds that promote spinogenesis, are capable of reducing the neural toxicity of beta-amyloid peptides, and/or reduce the symptoms of traumatic brain injury in a patient.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: September 14, 2021
    Assignee: Spinogenix, Inc.
    Inventors: Stella Sarraf, Vincent F. Simmon, Gerald F. Swiss